Novartis to Launch Direct-to-Patient Cosentyx Platform in US
Novartis will launch a US direct-to-patient platform on November 1, 2025, offering select units of Cosentyx at a 55%...
Jon Napitupulu
Cosmos Health Secures $300M for US Growth & AI Innovation
Cosmos Health has outlined a sweeping restructuring and growth plan anchored by an up to $300 million financing facility...
Neura Health Secures $11.4M for Neurology Care Expansion
Neura Health has raised $11.4 million in Series A financing, led by the American Heart Association’s Go Red for...
Apyx Medical to Spotlight New Ayon Body Contouring System
Apyx Medical is moving into full commercial mode for its new AYON body contouring system and will host a...
Novartis Begins Tender Offer to Acquire Tourmaline Bio
Novartis has launched a cash tender offer to acquire all outstanding shares of Tourmaline Bio at $48 per share,...
IO Biotech Provides Update Following FDA Pre-BLA Meeting
FDA has advised IO Biotech not to submit a biologics license application for Cylembio in first-line advanced melanoma after...
Inventiva’s New 2025 Financials: The Results Are Here
Inventiva reported first-half 2025 results and a materially extended cash runway on the back of a €115.6 million second...
Clinuvel’s Breakthrough: New Pharmaceutical Formulations Advance
Clinuvel is advancing sustained-release liquid formulations for peptides into preclinical development, targeting multiple release profiles with an initial focus...
Profusa and Medical University of Graz Announce Collaboration
Profusa deepens its European presence through a strategic collaboration with Prof. Dr. Marianne Brodmann at the Medical University of...
Kraig Labs Reaches Full Operational Status for International Order
Kraig Biocraft Laboratories’ opening of its second Southeast Asian silk production facility marks a significant step towards commercial-scale production...